611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net
Medical Disorders
Resources
Basic InformationLookupsLatest News
Many U.S. Seniors May Need Better Knee Arthritis CareAfter COVID, Many Americans Are Struck by New Maladies: StudyCataracts: Common, and Easy to TreatThere Are Many Good Reasons for Kids to Get the COVID VaccineBabies Produce Strong Immune Response to Ward Off COVID-19: StudyNovavax's COVID Vaccine Shines in Latest TrialAHA News: U.S. Appears to Lose Ground in Controlling High Blood PressureOdds for Death, Hospital Care Rise When Statins Are StoppedWeight-Loss Surgeries Used Least in U.S. States That Need Them MostObesity Could Raise Odds for 'Long-Haul' COVID SymptomsSmokers, Obese People Need Major Heart Interventions Earlier in LifeOld Age No Bar to Successful Heart Transplant, Study FindsCOVID Antibody Treatment Is Safe, Effective in Transplant PatientsThere Is No 'Healthy Obesity,' Study FindsExpiration Dates on Johnson & Johnson COVID Vaccine ExtendedWill People Really Need a Yearly COVID Booster Vaccine?America Is Losing the War Against DiabetesGene Editing Technique Corrects Sickle Cell Disease in MiceCOVID Vaccines Appear Safe for People With IBDNew Treatment Fights Rare Cases of Vaccine-Linked Blood ClotsWoman Dies From Dengue Fever Acquired in FloridaAstraZeneca COVID Vaccine Tied to Rare Cases of Low Blood PlateletsWhy a COVID Diagnosis Could Cost You Way More Money in 2021New Links Between Poor Sleep, Diabetes and DeathVaccinations More Urgent as Variant That Crippled India Shows Up in the U.S.Think You Can Skip That Annual Physical?  Think AgainReal-World Study Shows Power of Pfizer, Moderna Vaccines to Prevent COVIDDeath Rates Are Rising Across Rural AmericaWhat Diet Is Most Likely to Help Ease Crohn's Disease?'Breakthrough' COVID Infections May Be Common in Vaccinated Transplant PatientsYour Teen's Smartphone Could Be Key to Unhealthy WeightToo Much Caffeine Might Raise Your Odds for GlaucomaPeople of Color Have Twice the Risk of Dying After Brain Injury, Study FindsStudy Pinpoints Cancer Patients at Highest Risk From COVIDMany Existing Drugs Could Be Potent COVID Fighters: StudyAntibiotics Won't Help Fight Lung-Scarring Disease IDF: StudyNew Disabilities Plague Half of COVID Survivors After Hospital DischargeDeclining Vaccination Rates Threaten Biden's July 4 GoalYour Doctor Appointments Might Look Different Post-PandemicPrior COVID Infection May Shield You From Another for at Least 10 MonthsTeens: You Got Your COVID Vaccine, What Now?White House Lists Countries Getting First Batch of Extra COVID VaccinesStrokes Hitting COVID Patients Are More Severe: StudyAverage COVID Hospital Bill for U.S. Seniors Nearly $22,000Deep Brain Stimulation Therapy May Help Parkinson's Patients Long TermNIH Starts Trial Assessing 'Mix & Match' COVID Vaccine ApproachAllergy Treatment Crucial If Your Child Has AsthmaScientists Discover Rare Form of ALS That Can Strike KidsGlobal Warming to Blame for 1 in 3 Heat-Related Deaths WorldwideBlood Sugar Tests Using Sweat, Not Blood? They Could Be on the Way
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

New Treatment Fights Rare Cases of Vaccine-Linked Blood Clots

HealthDay News
by Robert Preidt
Updated: Jun 10th 2021

new article illustration

THURSDAY, June 10, 2021 (HealthDay News) -- Very rarely, blood clots can develop after COVID-19 vaccination, and doctors in Canada describe a new test and treatment for the condition in a case study of three patients.

All three developed the condition called vaccine-induced immune thrombotic thrombocytopenia (VITT) after receiving the AstraZeneca vaccine.

Two developed blood clots in their legs, and the third had blood clots blocking arteries and veins inside the brain, according to researchers at McMaster University in Ontario.

The patients recovered after receiving treatment that combined anti-clotting drugs and high doses of intravenous immunoglobulin.

The study was published June 9 in the New England Journal of Medicine.

"If you were a patient with VITT, I'd be telling you we know of a treatment approach. We can diagnose it accurately with our tests, treat it and we know exactly how the treatment works," said study author Ishac Nazy, scientific director of the McMaster Platelet Immunology Laboratory.

"Our job is to understand this disease mechanism so we can improve diagnosis and patient management. This study brings together successful lab diagnostics and patient care. It's a true translational medicine approach, which is really our forte, bench-side to bedside," Nazy said in a university news release.

VITT occurs when antibodies attack a blood protein called platelet factor 4 (PF4). This activates platelets in the blood, causing them to clump together and form clots, the study authors explained.

Blood samples taken from the three patients after treatment showed reduced antibody-mediated platelet activation in all of them.

The McMaster team developed an effective VITT test and treatment by building on their previous research of heparin-induced thrombocytopaenia (HIT). The two conditions are similar, but using a standard HIT antibody test to detect VITT can yield false negative results.

The researchers modified the HIT test to detect VITT-specific antibodies found in rare cases of patients who've received a COVID-19 vaccine.

"We now understand the mechanism that leads to platelet activation and clotting," Nazy said.

More information

The U.S. Centers for Disease Control and Prevention has more on COVID-19 vaccines.


SOURCE: McMaster University, news release, June 9, 2021